JPS63500893A - Methods for attaching biological materials to solid substrates - Google Patents
Methods for attaching biological materials to solid substratesInfo
- Publication number
- JPS63500893A JPS63500893A JP50451786A JP50451786A JPS63500893A JP S63500893 A JPS63500893 A JP S63500893A JP 50451786 A JP50451786 A JP 50451786A JP 50451786 A JP50451786 A JP 50451786A JP S63500893 A JPS63500893 A JP S63500893A
- Authority
- JP
- Japan
- Prior art keywords
- biological
- substrate
- group
- substances
- ion bombardment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 48
- 239000000758 substrate Substances 0.000 title claims description 36
- 239000012620 biological material Substances 0.000 title claims description 16
- 239000007787 solid Substances 0.000 title claims description 8
- 239000000126 substance Substances 0.000 claims description 25
- 238000010849 ion bombardment Methods 0.000 claims description 20
- 229920003023 plastic Polymers 0.000 claims description 19
- 239000004033 plastic Substances 0.000 claims description 18
- 239000007790 solid phase Substances 0.000 claims description 13
- -1 polypropylene Polymers 0.000 claims description 11
- 210000003743 erythrocyte Anatomy 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 239000004743 Polypropylene Substances 0.000 claims description 9
- 229920001155 polypropylene Polymers 0.000 claims description 9
- 210000004027 cell Anatomy 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 5
- 229920002799 BoPET Polymers 0.000 claims description 4
- 239000005041 Mylar™ Substances 0.000 claims description 4
- 239000004793 Polystyrene Substances 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000004809 Teflon Substances 0.000 claims description 4
- 229920006362 Teflon® Polymers 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 229920002223 polystyrene Polymers 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 3
- 239000005556 hormone Substances 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108060003951 Immunoglobulin Proteins 0.000 claims description 2
- 241000700605 Viruses Species 0.000 claims description 2
- 230000001413 cellular effect Effects 0.000 claims description 2
- 102000018358 immunoglobulin Human genes 0.000 claims description 2
- 229940072221 immunoglobulins Drugs 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 102000006395 Globulins Human genes 0.000 claims 2
- 108010044091 Globulins Proteins 0.000 claims 2
- 108010015776 Glucose oxidase Proteins 0.000 claims 1
- 239000004366 Glucose oxidase Substances 0.000 claims 1
- 241000220317 Rosa Species 0.000 claims 1
- 239000013566 allergen Substances 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 claims 1
- 229940116332 glucose oxidase Drugs 0.000 claims 1
- 235000019420 glucose oxidase Nutrition 0.000 claims 1
- 210000000265 leukocyte Anatomy 0.000 claims 1
- 230000027455 binding Effects 0.000 description 15
- 230000000694 effects Effects 0.000 description 12
- 150000002500 ions Chemical class 0.000 description 11
- 239000000427 antigen Substances 0.000 description 10
- 102000036639 antigens Human genes 0.000 description 10
- 108091007433 antigens Proteins 0.000 description 10
- 239000001506 calcium phosphate Substances 0.000 description 6
- 229910000389 calcium phosphate Inorganic materials 0.000 description 6
- 235000011010 calcium phosphates Nutrition 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 6
- 238000010884 ion-beam technique Methods 0.000 description 5
- 239000010408 film Substances 0.000 description 4
- 230000035939 shock Effects 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000005865 ionizing radiation Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000009870 specific binding Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 238000000975 co-precipitation Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000004544 sputter deposition Methods 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 241000239218 Limulus Species 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000219833 Phaseolus Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 229940070318 chlo-amine Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- SOYKEARSMXGVTM-HNNXBMFYSA-N dexchlorpheniramine Chemical compound C1([C@H](CCN(C)C)C=2N=CC=CC=2)=CC=C(Cl)C=C1 SOYKEARSMXGVTM-HNNXBMFYSA-N 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- DCSRPHQBFSYJNN-UHFFFAOYSA-L disodium 4-[(2-arsonophenyl)diazenyl]-3-hydroxynaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].Oc1c(N=Nc2ccccc2[As](O)(O)=O)c2ccc(cc2cc1S([O-])(=O)=O)S([O-])(=O)=O DCSRPHQBFSYJNN-UHFFFAOYSA-L 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/545—Synthetic resin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C59/00—Surface shaping of articles, e.g. embossing; Apparatus therefor
- B29C59/16—Surface shaping of articles, e.g. embossing; Apparatus therefor by wave energy or particle radiation, e.g. infrared heating
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/548—Carbohydrates, e.g. dextran
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/552—Glass or silica
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C35/00—Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
- B29C35/02—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
- B29C35/08—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
- B29C35/0866—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using particle radiation
- B29C2035/0872—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using particle radiation using ion-radiation, e.g. alpha-rays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/753—Medical equipment; Accessories therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるため要約のデータは記録されません。 (57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】 固体基質に生物学的物質を付着する方法本発明は生物学的物質を固体基質に付着 する方法に関し、制限的ではないが、とくに抗原および/または抗体のような生 物学的物質を固相イムノアッセイに用いられる固相基質に付着する方法に関する 。本発明は、また該方法の使用によって製造される生成物に関する。[Detailed description of the invention] Method for attaching biological substances to solid substrates The present invention provides methods for attaching biological substances to solid substrates. In particular, but not exclusively, biological agents such as antigens and/or antibodies may be used. Concerning methods for attaching physical substances to solid phase substrates used in solid phase immunoassays . The invention also relates to products produced by use of the method.
免疫学的反応におけるパートナ−のうちの一方を固体支持体に結合させることは 、該反応の定量的および/または定性的測定を容易にさせる。一般的には、パー トナ−の一方の免疫化により、反応成分の、未反応成分からの分離が容易になる 。実際には、反応における固定化パートナ−はその相補的反応体を溶液から捕獲 し、それを固相に結合させている。この固相への結合がなされると、その存在を 定量的または定性的に測定することができる。Attaching one of the partners in an immunological reaction to a solid support is , facilitating quantitative and/or qualitative measurement of the reaction. In general, par Immunization of one side of the toner facilitates separation of reactive components from unreacted components. . In effect, the immobilized partner in the reaction captures its complementary reactant from solution. and binds it to a solid phase. Once this binding to the solid phase is achieved, the presence of Can be measured quantitatively or qualitatively.
これまでは、免疫学的反応におけるパートナ−の一方の固定化は、種々の異なる 方法でなされている。使用される支持物質にはセルロース、アガロース、デキス トリン、ポリアクリルアミド、ガラス、ゴム、およびナイロン、ポリスチレン、 ポリエステル等のプラスデックが包含される。共有結合を生じるような直接的な 化学結合も使用することができる。抗原または抗体のいずれかを支持物質に結合 させることからなる化学的方法にはグルタルアルデヒド、シアノゲンブロマイド 、カルボジイミドおよびアミノアルキルシランの使用が包含される。これらの技 術は当業者にはよく知られている。Up until now, immobilization of one of the partners in an immunological reaction has been performed using a variety of different methods. It's done in a way. Support materials used include cellulose, agarose, and dextrose. Thorin, polyacrylamide, glass, rubber, and nylon, polystyrene, Includes plus decks such as polyester. direct, such as those that result in covalent bonds; Chemical bonds can also be used. Binding either antigen or antibody to supporting material The chemical method consisting of glutaraldehyde, cyanogen bromide , carbodiimides and aminoalkylsilanes. these techniques The techniques are well known to those skilled in the art.
抗原または抗体のプラスチック表面への結合は直接的な吸着によって達成するこ ともできる。これは簡単な結合法であるが、いくつかの欠点を有する。抗原また は抗体の表面への吸着は疎水的相互作用およびファンデルワールス力によって達 成される。これらは、比較体支持体の取り扱いの間に表面から溶離しうる。(1 )参照。Binding of antigens or antibodies to plastic surfaces can be achieved by direct adsorption. Can also be done. Although this is a simple coupling method, it has some drawbacks. antigen or The adsorption of antibodies onto surfaces is achieved through hydrophobic interactions and van der Waals forces. will be accomplished. These may elute from the surface during handling of the comparator support. (1 )reference.
マイクロタイター・プレートのような固定支持体を用いる場合、種々の抗原の結 合する能力はその生化学的組成に応じ変化しうる。When using a fixed support such as a microtiter plate, binding of various antigens is possible. The ability to combine may vary depending on its biochemical composition.
加えて、かかるプレートへの抗原の結合力は、当該プレート上の種々のウェルの 間で大きく変化しうる。(2)参照。In addition, the binding strength of the antigen to such a plate is determined by the binding strength of the antigen to the various wells on the plate. can vary greatly between See (2).
これらの問題を打ち勝つための技術にはプラスチック表面の予備活性化が包含さ れる。予備活性化の2つの化学的方法はヨーロッパ特許第83111144号お よびヨーロッパ特許第84103367号に開示されている。これらの方法には フェニルアラニンリジン・コポリマーおよびジフェニレン−ビス−ジアゾニウム 化合物を各々用いた予備活性化が包含される。Techniques to overcome these problems include preactivation of plastic surfaces. It will be done. Two chemical methods of preactivation are described in European Patent No. 83111144 and and European Patent No. 84103367. These methods include Phenylalanine lysine copolymer and diphenylene-bis-diazonium Preactivation with each compound is included.
プラスチックマイクロタイター・プレート活性化の物理的方法はヨーロッパ特許 第82102257号に記載されている。この方法にはマイクロタイター・プレ ートのγ線への暴露が伴う。γ照射は、イオン化作用に基づきより良好な結合( およびまた滅菌)が得られ、ある種の遊離基/結合の存在につながる。(3)参 照。Physical method of plastic microtiter plate activation is European patented No. 82102257. This method requires a microtiter plate. It involves exposure to gamma radiation. γ irradiation produces better bonding ( and also sterility) is obtained, leading to the presence of certain free radicals/bonds. (3) Reference Light.
抗体および抗原のような可溶性物質に加え、免疫学的または生物学的反応系に使 用される単数または複数の細胞抽出物自体を固定化することも、また必要である 。結合は当業者に知られた方法を用いて促進することもできる。(4)参照。こ れら技術には、一般にグルタルアルデヒド、ポリーL−リジン、フェニルアラニ ンリジンコポリマーまたはレクチン[グリシン・マックス(Glycine m ax)、リムラス・ポリエステ s culinaris)およびファセオルス・ブルガリス(Phaseolu s vulgariS)等の供給源から得られたちのコのような薬剤を用いた固 体支持体の前処理が包含される。また、細胞は固体支持体に、まず細胞に特異的 な抗体を支持体に結合することによって結合することができる。In addition to soluble substances such as antibodies and antigens, they can be used in immunological or biological reaction systems. It is also necessary to immobilize the cell extract or extracts used themselves. . Binding can also be facilitated using methods known to those skilled in the art. See (4). child These technologies generally include glutaraldehyde, poly-L-lysine, and phenylalanine. Lysine copolymer or lectin [Glycine m ax), Limulus Polyester sculinaris) and Phaseolus vulgaris (Phaseolu s vulgari S) and other sources. Pretreatment of the body support is included. In addition, cells are first placed on a solid support and The binding can be achieved by binding a specific antibody to a support.
抗体の結合は前記した方法で達成することができる。Binding of antibodies can be accomplished as described above.
前記した結合法は、全て基質上の反応基の存在に依存している。The coupling methods described above all rely on the presence of reactive groups on the substrate.
結合法に包含されないのなら、結合した抗原、抗体、細胞等は、それらによりイ ムノアッセイ法の後の工程に使用される他の物質の非特異的結合を許容しうるの で、イムノアッセイに使用する前に反応基を中和する必要がある。物質のこの非 特異的結合は高い基底値の読み取りにつながり、したがってテスト法の感度を制 限する。また、生物学的物質の生化学によって、使用されうる特異的な結合法が 決定され、したがって全てのタイプの生物学的物質を特定の基質に有効に結合さ せることができる不変的に適用可能な結合技術は、全く存在しない。If not included in the binding method, the bound antigen, antibody, cell, etc. Can tolerate non-specific binding of other substances used in subsequent steps of the immunoassay method? Therefore, the reactive groups must be neutralized before use in immunoassays. This non-existence of matter Specific binding leads to high basal readings and therefore limits the sensitivity of the test method. limit The biochemistry of the biological material also dictates the specific binding methods that can be used. determined, and therefore effective binding of all types of biological substances to specific substrates. There is no permanently applicable bonding technique that can be applied.
本発明者らによれば、生物学的物質の固相基質への結合が、イオンビーム・衝撃 法の使用によって達成できることが判明するに至った。According to the present inventors, binding of biological materials to solid substrates can be achieved by ion beam or bombardment. It has now become clear that this can be achieved through the use of law.
本発明に従えば、 (i)固相基質をイオン衝撃(イオンボンバードメント)に付し、(ii)処理 した該基質をそこに付着される生物学的物質と接触させる 工程からなることを特徴とする生物学的物質を固相基質に付着させる方法が提供 される。According to the invention, (i) subjecting the solid phase substrate to ion bombardment; (ii) treating contacting the substrate with biological material to be attached thereto. Provided is a method for attaching a biological material to a solid substrate, the method comprising: be done.
本発明は、また前記した方法によって製造される生成物を提供するものである。The present invention also provides products produced by the method described above.
この態様において、本発明は固相基質、イオン衝撃によって処理された表面およ び処理した該表面に付着された生物学的物質からなる固相生成物を包含する。In this embodiment, the invention provides a solid phase substrate, a surface treated by ion bombardment and and a solid phase product consisting of biological material attached to the treated surface.
本発明に用いられる適当な生物学的物質には抗原、抗体、免疫グロブリン例えば IgG、IgMおよびIgE、および酵素のような蛋白質物質、並びに赤血球細 胞膜、細胞自体、例えば細菌およびウィルス、およびホルモン、例えばチロイド 刺激ホルモン(TSH)のような細胞物質が包含される。適当な固相基質には、 制限的ではないが特にプラスチック物質、例えばポリプロピレン、マイラー、ポ リスチレン、ラテックスおよびテフロン:ガラスおよびシリカ:およびセルロー スおよびセルロース誘導体が包含される。Suitable biological materials for use in the present invention include antigens, antibodies, immunoglobulins, e.g. Protein substances such as IgG, IgM and IgE, and enzymes, as well as red blood cells the cell membrane, the cell itself, e.g. bacteria and viruses, and hormones, e.g. thyroids Cellular substances such as stimulating hormone (TSH) are included. Suitable solid phase substrates include: In particular, but not exclusively, plastic materials such as polypropylene, mylar, polymer Listyrene, Latex and Teflon: Glass and Silica: and Cellulose and cellulose derivatives.
本発明者らは、イオンビーム・衝撃法の使用により、高い親和性、安定性および 再生産性をもって生物学的物質の固相基質への特異的結合が可能となった。Through the use of ion beam bombardment methods, we have achieved high affinity, stability and It has become possible to reproducibly and specifically bind biological substances to solid-phase substrates.
イオンビーム・衝撃法は、一般によく知られているが((5)参照)、該方法は 生物学的物質付着用の基質の前処理には使用されていない。The ion beam bombardment method is generally well known (see (5)), but this method It is not used to pre-treat substrates for biological attachment.
例えば、米国特許第3682729.4256780および4457972号は 、全て金属膜および類似物質の基質上への形成または沈積におけるイオン衝撃の 使用を記載しているものである(ボーデおよびサンドグレンの(6)も同様に参 照)。しかしながら、これら先行する開示には生物学的物質の基質への付着にお けるこの技術の使用に関するいずれの文献も全く含まれていない。For example, U.S. Pat. , all due to ion bombardment in the formation or deposition of metal films and similar materials onto substrates. (See also (6) of Bode and Sandgren). (see). However, these prior disclosures do not address the issue of attachment of biological materials to substrates. It does not contain any literature regarding the use of this technique.
固相基質のイオン衝撃の工程は、例えば該基質にエネルギーAr+イオンのビー ムで衝撃を加えることによって、行なうことができる。処理したかかる基質への 生物学的物質の強力な付着をもたらす正確なメカニズムは現在、十分には理解さ れていないが、イオン衝撃により、境界面の強力な結合をもたらす1または2以 上の以下の効果が得られるものと考えられる。The process of ion bombardment of a solid-phase substrate may involve, for example, bombarding the substrate with a beam of energetic Ar+ ions. This can be done by applying a shock with a drum. to such treated substrates. The exact mechanisms leading to strong adhesion of biological materials are currently not fully understood. However, due to ion bombardment, one or more It is thought that the following effects can be obtained.
(a)スパッタリングによる表面不純物の除去;(b)生物学的物質に付着する 準安定化学的「ダンプリング」ボンド、および CC)優先的スパッタリングによる表面組成の変性。(a) removal of surface impurities by sputtering; (b) adhesion to biological materials metastable chemical “dumpling” bonds, and CC) Modification of surface composition by preferential sputtering.
イオン衝撃の効果は、穏やかな電離線(γ線、X線、高エネルギー電子、パイル ・イラジェーション等)によるポリマー材料との公知の相互作用と比較すると、 非常に特異的である。(7)参照。イオン衝撃によって多量のイオン化密度(阻 止能)が得られ、また原子反跳を得ることができるので、穏やかな形の電離線ま たは通常の平衡化学では達し得なかった準安定化学的表面状態/組成を生成する ことができる。この意味で、イオン衝撃法は穏やかな電離線によって得られると 同様な効果ばかりでなく、多量の新規な準安定化学状態(ダンプリングボンド) をも生成できる点で、非常に特異的であると考えられる。この特徴点が、種々の タイプの生物学的物質の、いくつかの異なるタイプのプラスチックへの結合の向 上が得られるイオン衝撃による普遍的な成功をもたらすものと思われる。The effect of ion bombardment is the effect of mild ionizing radiation (gamma rays, X-rays, high-energy electrons, ・Irradiation, etc.) compared to known interactions with polymeric materials. Very specific. See (7). A large amount of ionization density (blocking) is generated by ion bombardment. Because it is possible to obtain atomic recoil (stopping ability) and atomic recoil, it is possible to use mild ionizing radiation or or create metastable chemical surface states/compositions that cannot be achieved by conventional equilibrium chemistry. be able to. In this sense, the ion bombardment method can be obtained using mild ionizing radiation. Not only similar effects but also a large number of novel metastable chemical states (dumpling bonds) It is considered to be very specific in that it can also generate . This characteristic point can be used for various The binding orientation of several types of biological materials to several different types of plastics The above results seem to bring about universal success with ion bombardment.
イオンビーム・衝撃の技術自体は公知であるので、本発明や方法におけるこの工 程は任意の標準的装置を用いることで、達成することができる。(5)参照。Since the ion beam/impact technology itself is well known, this technique in the present invention and method is not applicable. This process can be accomplished using any standard equipment. See (5).
同相基質物質の衝撃の後、ついで生物学的物質を処理した基質と接触させる。本 発明の特異的結合法は、室温で行うことができ、いずれの外部的な化学的結合剤 をも必要としない。この点において、生物学的物質と処理した基質物質の間に直 接的な結合が得られ、さらに、該生物学的物質は、付着工程の間に照射または化 学的処理されないので、いずれの方法でも分解または破壊されない。After bombardment with the in-phase substrate material, biological material is then contacted with the treated substrate. Book The inventive specific binding method can be performed at room temperature and does not require any external chemical binding agents. It doesn't even need . In this respect, there is a direct relationship between the biological material and the treated substrate material. Direct binding is obtained, and the biological material is not irradiated or chemically treated during the attachment process. Since it is not chemically treated, it cannot be degraded or destroyed in any way.
以下に詳細に記載するように、本発明の一興体例において、本発明の方法を用い て赤血球膜を、テスト基質として選ばれた透明プラスチック固相基質、すなわち ポリプロピレンである第1基質(これは反応基を全く有していない。)およびマ イラーである第2基質(これは若干の反応基を有する。)に結合させる。エネル ギーAr+イオンビームによるプラスチック基質の衝撃後に、ついで、適当な液 体中のコロイド状懸濁液の赤血球膜を系中(真空)のイオン衝撃で処理した表面 上に注入する。該液体は急速に広がって薄膜を形成し、赤血球膜は基質表面に強 力に結合するので、水中の長期間の超音波処理でも該膜の表面からの剥がれにお いて全く影響を与えない。As described in detail below, in one embodiment of the present invention, the method of the present invention is used. The red blood cell membrane was transferred to a transparent plastic solid phase substrate chosen as the test substrate, i.e. A first substrate which is polypropylene (which has no reactive groups) and a matrix a second substrate, which has some reactive groups. energy After bombardment of the plastic substrate with the Ar + ion beam, a suitable liquid is then applied. Surface of red blood cell membranes in colloidal suspension in the body treated with ion bombardment in a system (vacuum) Inject on top. The fluid spreads rapidly to form a thin film, and the red blood cell membrane tightens against the substrate surface. Because it is bonded to the force, the film will not peel off from the surface even during long-term ultrasonic treatment underwater. It has no effect at all.
さらに、本発明の特徴点を以下に示した実施例から明らかにするが、これらは本 発明を何ら制限するものではない。これらの実施例において、ポリプロピレン、 テフロン、ポリスチレンおよびマイラーの小片(1czx、1. 5CIl+) をトリクロロエチレンで清浄し、ついでメタノールで洗浄し、風乾した。試料を 圧力<1xlO−5トルに排気したイオン衝撃・チャンバー(第1図)に取り付 けた。試料を5xlO”−5xlO”イオン/cIR’の線量範囲の60KeV のAr+またはHe+イオンで衝撃する。長方形小片試料の半分の城主に衝撃を 加え、実施例1記載の赤血球実験に使用した。環状ディスクは該埴土全体であっ て、他の実施例記載の実験に使用した。詳細に実験したいくつかの衝撃・パラメ ーターはイオン線量、線引率、イオン種および衝撃後の周囲の貯蔵環境(生物学 的物質を接触させるまで)である。広範な再現性のチェックを行った。Furthermore, the characteristic points of the present invention will be clarified from the examples shown below, but these are This does not limit the invention in any way. In these examples, polypropylene, Small pieces of Teflon, polystyrene and mylar (1czx, 1.5CIl+) was cleaned with trichlorethylene, then methanol, and air dried. sample Installed in an ion bombardment chamber (Figure 1) evacuated to a pressure <1xlO-5 Torr. I got it. The sample was heated to 60 KeV with a dose range of 5xlO"-5xlO" ions/cIR'. bombarded with Ar+ or He+ ions. Impact on half of the castle owner of the rectangular small piece sample In addition, it was used in the red blood cell experiment described in Example 1. The annular disk covers the entire clay. and used in experiments described in other examples. Some shocks and parameters tested in detail The meter is based on ion dose, draw rate, ion species and the surrounding post-shock storage environment (biological (until contact with target substance). Extensive reproducibility checks were performed.
赤血球細胞膜を新鮮な抗凝固血液からリン酸カルシウム共沈法によって調製した 。(8)参照。アジ化ナトリウムを最終濃度0.1%で混和して該試料のプラス チック基質表面への付着処理の間の細菌汚染を抑制した。Red blood cell membranes were prepared from fresh anticoagulated blood by calcium phosphate coprecipitation method. . See (8). Add sodium azide to the sample at a final concentration of 0.1%. Bacterial contamination during the adhesion process to the tick substrate surface was suppressed.
B、細胞膜の基質への付着 ポリプロピレン小片を第1図に図示した装置によりAr+イオンで処理した。小 片を、系全体を真空に維持したターゲット・チャンバー10内の試料ホルダー1 1に入れ、開口ブレート13を介して加速したAr+イオン12で衝撃を加える 。B. Attachment of cell membrane to substrate A piece of polypropylene was treated with Ar+ ions using the apparatus illustrated in FIG. small The sample holder 1 is placed in a target chamber 10 in which the entire system is kept in vacuum. 1 and apply a shock with accelerated Ar+ ions 12 through the aperture plate 13. .
該小片のイオン衝撃後、試料ホルダー11をエアーロックバルブ20を介して隣 接したエアーロック21に真空状態を乱さないで移動させた(第1図)。エアー ロック21において、ついで制御した容量の赤血球細胞膜・リン酸カルシウム懸 濁液をプラスチック小片上に、生物学的物質注入口22を介して注入した。液体 はポリプロピレンの非衝撃域を湿潤せずに、急速に広がって衝撃埴土で被膜を形 成する。プラスチック小片をエアーロックから取り出し、過剰の液体を除去した 。風乾させた後、赤血球細胞膜/リン酸カルシウム混合物の付着力について該小 片を水中に浸漬し、ついで5分間超音波洗浄に付すことで、評価した。該小片を 風乾し、ついで光学顕微鏡で調べた。第28および2b図は、各々、ポリプロピ レンおよびマイラー上の衝撃域および非衝撃域の結果を示す。After the ion bombardment of the small piece, the sample holder 11 is placed next to it via the air lock valve 20. It was moved to the airlock 21 in contact without disturbing the vacuum state (Fig. 1). air In Lock 21, a controlled volume of red blood cell membrane/calcium phosphate suspension is then added. The suspension was injected onto the plastic piece through the biological material inlet 22. liquid spreads rapidly to form a coating with impact clay without wetting the non-impact area of the polypropylene. to be accomplished. The plastic piece was removed from the airlock and excess liquid was removed. . After air drying, the adhesion of the red blood cell membrane/calcium phosphate mixture was evaluated. The pieces were evaluated by immersing them in water and then subjecting them to ultrasonic cleaning for 5 minutes. the small piece It was air dried and then examined under an optical microscope. Figures 28 and 2b each show polypropylene Impact and non-impact zone results are shown on Len and Mylar.
付着膜/リン酸カルシウム混合物はこれらの顕微鏡図において暗く見える。膜/ リン酸カルシウム混合物は衝撃域に結合し、非衝撃未処理域には結合していない ことが明白に示されている。The attached film/calcium phosphate mixture appears dark in these micrographs. film/ Calcium phosphate mixture binds to the impact zone and not to the non-shock untreated zone That is clearly shown.
実施例2 IgGをヒト血清から、セファローズ−スタッフA・アフィニティ・カラムクロ マトグラフィで精製した。精製IgGのアリコートをクロアミンT法に従い+2 51でラジオラベルした。ラジオラベルIgGをトレサーとして精製IgGに添 加してラベルIgG:未ラベルIgGの比率=1:20〜l:30を得た。Example 2 IgG was extracted from human serum using Sepharose-Staff A affinity column chromatography. Purified by matography. Aliquots of purified IgG were added +2 according to the Chloamine T method. Radiolabeled with 51. Radiolabeled IgG is added to purified IgG as a tracer. In addition, a ratio of labeled IgG:unlabeled IgG of 1:20 to 1:30 was obtained.
ついで、このラジオラベル物質を用いて、IgGのイオン衝撃プラスチック表面 との相互作用に対するIgG濃度、緩衝液pHおよび反応時間の影響を調べた。Next, using this radiolabel substance, ion bombardment of IgG on the plastic surface was performed. The effects of IgG concentration, buffer pH, and reaction time on the interaction with were investigated.
これらの実験において、IgGはPH7,0のリン酸塩緩衝液およびpH9,6 の炭酸塩緩衝液中に濃度範囲10〜100μ9/叶に希釈した。試料40μgを イオン衝撃および未処理プラスチック片上に型穴された直径0.6CJIのウェ ルに加えた。室温でインキュベート後、鋏片を脱イオン水で洗浄し、ウェルを鋏 片から切り取り、付着1gGによるラジオ活性を7カウンターでカウントした。In these experiments, IgG was tested in phosphate buffer at pH 7.0 and in phosphate buffer at pH 9.6. diluted in carbonate buffer to concentrations ranging from 10 to 100 μ9/leaf. 40 μg of sample 0.6 CJI diameter wafer molded onto a piece of ion bombarded and untreated plastic. added to the file. After incubation at room temperature, wash the scissors with deionized water and remove the wells with the scissors. The pieces were cut and the radioactivity due to the attached 1gG was counted using a 7 counter.
緩衝液p)lは、イオン衝撃プラスチック表面に対し結合したIgGの量に実質 的な影響を与えないことが判明した。反応時間を長くすれば(18〜20時間) 、より多量のIgGの付着が可能になる。IgGの濃度を高くすれば、イオン衝 撃プラスチックに対し付着するIgGがより多量になる。The buffer p)l has a substantial effect on the amount of IgG bound to the ion bombarded plastic surface. It was found that it had no effect. If the reaction time is increased (18-20 hours) , allowing the attachment of larger amounts of IgG. If the concentration of IgG is increased, the ion bombardment will be increased. A larger amount of IgG adheres to the plastic.
第1表は、IgGの取り込みに対する種々の形のイオン衝撃および種々のプラス チックの影響を示す。この表から明らかなように、イオン衝撃によりIgGのプ ラスチック表面への取り込みを増加することができ、かつその効果は使用したイ オン種および使用したプラスチックのタイプによって変化するが判明した。Table 1 shows various forms of ion bombardment and various positive effects on IgG uptake. Showing the effects of tics. As is clear from this table, ion bombardment causes IgG to be It can increase the uptake into the plastic surface and the effect depends on the material used. It was found to vary depending on the species and the type of plastic used.
参考文献 第1表 種々のプラスチック基質に対するIgG付着のイオンビーム誘発増ポリプロピレ ン 288 349 テフロン 128 42 ポリスチレン 11389 前記実施例は本発明を説明するためにのみ用いたものであって、本明細書に広範 に記載したごとく本発明の範囲から逸脱しない限り、種々の変形例および変法も そこになすことができるものと認められる。References Table 1 Ion Beam-Induced Enhancement of IgG Attachment to Various Plastic Substrates Polypropylene 288 349 Teflon 128 42 Polystyrene 11389 The foregoing examples are used only to illustrate the invention and are not intended to be broadly interpreted herein. Various modifications and variations may be made without departing from the scope of the invention as described in It is recognized that what can be done there.
−チタン(シールド・ホランド、アムステルダム、1973年)(1)エングバ ル・イー、メソッド・イン・エンザイモロジイ、1980年、70巻、419〜 439頁 (2)チェフスム・ビー・ニスおよびアンマーク・ジェイ・アール、インコンス タント・EL I SA・ランセット、1978年、i: 161頁 (3)デュ・プレシス・ティ・エイおよびシュナウツ・エヌ・シイ、ジャーナル ・オブ・オイル・アンド・カラー・ケミスラ・アソシエーション(J、 Oil Co1. Chem、 As5oc、 )、1975年、58巻、85〜89 頁 (4)ヒュウザー・シイ・エイチ、ストッカー・ジェイ・ダブリユウおよびガイ スラー・アール・エイチ、細胞のプラスチックへの結ン・エイザイモロジイ、1 981年、73巻、406頁(5)ダーナリイ・シイ、フリーマン・ジエイ・エ イチ、ネルマン・アール・ニスおよびステフェン・ジェイ、イオン・インブラン チ(6)ボーデ・ビイおよびサンドグレン・ジェイ・イニ、蒸発したチタンのポ リエチレンへの付着:イオン衝撃前処理の効果、ジャーナル・オブ・バキューム ・サイエンス・アンド・チクノロシイA。-Titanium (Shield-Holland, Amsterdam, 1973) (1) Engva Lu Yi, Method in Enzymology, 1980, vol. 70, 419- 439 pages (2) Chevsum B Nis and Unmarked JR, Inc. Tanto EL I SA Lancet, 1978, i: 161 pages (3) Du Plessis T.A. and Schnautz N.C., Journal ・Of Oil and Color Chemistry Association (J, Oil Co1. Chem, As5oc, ), 1975, vol. 58, 85-89 page (4) Huuser C.H., Stocker J.D. and Guy Slur R.H., Cell-to-Plastic Attachment Theory, 1 981, vol. 73, p. 406 (5) Darnary C., Freeman G.E. Ichi, Nerman Earl Nis and Stephen Jay, Ion Imblanc Chi(6) Bodeby and Sandgren J.I., evaporated titanium pot. Adhesion to polyethylene: Effect of ion bombardment pretreatment, Journal of Vacuum ・Science and Chikunoroshii A.
2巻4号、to−12月、1984年 (7)フランク・エイチ・ビイ、ポリプロピレン(マクドナルド・チクノロシイ 、ロンドン、1968年)5章(8)クラ−コブスキー・ディ・ビイ、ヘモグロ ビン非含有ヒト赤血球ストロマ製造用のリン酸カルシウム共沈法、オーストラリ アン・ジャーナル・オブ・メディカル・ラボラトリイ・サイエンス、1984年 、5巻、124〜126頁 国際調査報告 ANNEX To THE I)JTERNATIONAL 5EARCHRE PORT 0NINTERNATIONAL APPLICATION No、 PCT/AU 86100235END OF ANNEXVolume 2, Issue 4, to December, 1984 (7) Frank H.B., Polypropylene (McDonald's Chikunoroshii) , London, 1968) Chapter 5 (8) Krakowski D. B., Hemoglos Calcium phosphate coprecipitation method for bottle-free human red blood cell stroma production, Australia Ann Journal of Medical Laboratory Science, 1984 , vol. 5, pp. 124-126. international search report ANNEX To THE I) JTERNATIONAL 5EARCHRE PORT NINTERNATIONAL APPLICATION No, PCT/AU 86100235END OF ANNEX
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPH202785 | 1985-08-19 | ||
AU2027 | 1985-08-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63500893A true JPS63500893A (en) | 1988-03-31 |
Family
ID=3771228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50451786A Pending JPS63500893A (en) | 1985-08-19 | 1986-08-18 | Methods for attaching biological materials to solid substrates |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0233257A4 (en) |
JP (1) | JPS63500893A (en) |
BR (1) | BR8606830A (en) |
DK (1) | DK200387D0 (en) |
FI (1) | FI871599A0 (en) |
HU (1) | HUT43092A (en) |
WO (1) | WO1987001120A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009123148A1 (en) * | 2008-03-31 | 2009-10-08 | 旭化成せんい株式会社 | Cellulose derivative fine particles, fluid dispersions of the same, solid dispersions thereof, and diagnostic drugs |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5055316A (en) * | 1988-04-20 | 1991-10-08 | Washington Research Foundation | Tight binding of proteins to surfaces |
US5389195A (en) * | 1991-03-07 | 1995-02-14 | Minnesota Mining And Manufacturing Company | Surface modification by accelerated plasma or ions |
DE19538523A1 (en) * | 1995-10-06 | 1997-04-10 | Helmut Prof Dr Kaeufer | Biocompatible plastics, processes for their production and areas of application |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3111474A1 (en) * | 1981-03-24 | 1982-10-07 | Behringwerke Ag, 3550 Marburg | "MEANS FOR IMMUNOLOGICAL DIAGNOSIS AND METHOD FOR THE PRODUCTION THEREOF" |
JPS5980442A (en) * | 1982-09-24 | 1984-05-09 | ベクトン・デイツキンソン・アンド・カンパニ− | Chemically modified surface for bonding large molecule |
-
1986
- 1986-08-18 EP EP19860905147 patent/EP0233257A4/en not_active Withdrawn
- 1986-08-18 JP JP50451786A patent/JPS63500893A/en active Pending
- 1986-08-18 WO PCT/AU1986/000235 patent/WO1987001120A1/en not_active Application Discontinuation
- 1986-08-18 BR BR8606830A patent/BR8606830A/en unknown
- 1986-08-18 HU HU864075A patent/HUT43092A/en unknown
-
1987
- 1987-04-13 FI FI871599A patent/FI871599A0/en not_active Application Discontinuation
- 1987-04-15 DK DK200387A patent/DK200387D0/en not_active Application Discontinuation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009123148A1 (en) * | 2008-03-31 | 2009-10-08 | 旭化成せんい株式会社 | Cellulose derivative fine particles, fluid dispersions of the same, solid dispersions thereof, and diagnostic drugs |
JP2015083696A (en) * | 2008-03-31 | 2015-04-30 | 旭化成せんい株式会社 | Cellulose derivative fine particle, liquid dispersion and dispersoid thereof, and diagnostic |
US9341622B2 (en) | 2008-03-31 | 2016-05-17 | Asahi Kasei Fibers Corporation | Cellulose derivative fine particle, dispersion liquid thereof, dispersion body thereof and diagnostic reagent |
JP5952522B2 (en) * | 2008-03-31 | 2016-07-13 | 旭化成株式会社 | Cellulose derivative fine particles, dispersion thereof, dispersion thereof and diagnostic agent |
Also Published As
Publication number | Publication date |
---|---|
EP0233257A1 (en) | 1987-08-26 |
EP0233257A4 (en) | 1989-01-26 |
WO1987001120A1 (en) | 1987-02-26 |
DK200387A (en) | 1987-04-15 |
FI871599A (en) | 1987-04-13 |
HUT43092A (en) | 1987-09-28 |
DK200387D0 (en) | 1987-04-15 |
BR8606830A (en) | 1987-10-27 |
FI871599A0 (en) | 1987-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4657873A (en) | Preactivated plastics surfaces for immobilizing organo-chemical and biologic materials | |
US4886836A (en) | Activated medium with low non-specific protein adsorption | |
US4357311A (en) | Substrate for immunoassay and means of preparing same | |
US3966897A (en) | Medium for use in bioassay and method of using same | |
US4177253A (en) | Magnetic particles for immunoassay | |
GB2103791A (en) | Carrier bound immunosorbent | |
JPS5980442A (en) | Chemically modified surface for bonding large molecule | |
CA1163193A (en) | Mycobacteria tuberculosis for immunoassay | |
CS223818B2 (en) | Means for afinity for the jeundice virus | |
JP2011523702A (en) | sensor | |
US4575484A (en) | Binding assay for the detection of mycobacteria | |
JPS63500893A (en) | Methods for attaching biological materials to solid substrates | |
US4489158A (en) | Binding assay for the detection of mycobacteria | |
US20040082766A1 (en) | Method of purifying biological substances, kit for purifying biological substances, and system for analyzing biological substances | |
AU605746B2 (en) | Method of attaching biological substances to solid substrates | |
CA1288046C (en) | Process for the separation of antifactor viii:c antibodies, more particularly usable for the purification of the blood plasma of a type a hemophiliac | |
CA1187786A (en) | Agent for immunological diagnosis and a process for its preparation | |
US4187075A (en) | Method of analyzing biological, liquid specimens for antigens or antibodies | |
JPS60222774A (en) | Activated solid phase body and activating method thereof andimmunological reactive solid phase body and manufacture and check method thereof | |
Kurosawa et al. | Adsorption of F (AB') 2 Anti-Human Immunoglobulin G to Plasma-Polymerized Allylamine Film Covered on a Silver Plate | |
JPH052940B2 (en) | ||
JPH01248570A (en) | Photosensor using avidin-biotin and manufacture thereof | |
Lachmann et al. | C6–C7: A further “complement supergene” | |
Kumakura et al. | Immobilization of antibodies and enzyme-labeled antibodies by radiation polymerization | |
JPH07151758A (en) | Method for immobilizing antibiotic by photochemical reaction on carrier, and lps, microorganism catching method, and determining method using the carrier |